Your session is about to expire
← Back to Search
Hydrogen Peroxide for Skin Cancer
Phase 2
Waitlist Available
Led By Jinka Sathya, MD
Research Sponsored by Jinka Sathya
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at study completion, an approximate of 1 year
Awards & highlights
Study Summary
This trial will test whether 30% hydrogen peroxide can help reduce the size of cancerous lesions, potentially avoiding surgery or radiation.
Eligible Conditions
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at study completion, an approximate of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study completion, an approximate of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in lesion size
Secondary outcome measures
Adverse Events
Change in the size of the radiation field
Local Control
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: 30% hydrogen peroxideExperimental Treatment1 Intervention
30% hydrogen peroxide liquid topical application. 2 drops (0.10 ml) of hydrogen peroxide solution per centimeter of lesion. Once every week for continuous 4 weeks. If there is complete clinical response, further hydrogen peroxide will not be done.
Group II: 3% hydrogen peroxidePlacebo Group1 Intervention
3% hydrogen peroxide liquid topical application. 2 drops (0.10 ml) of hydrogen peroxide solution per centimeter of lesion. Once every week for continuous 4 weeks. If there is complete clinical response, further hydrogen peroxide will not be done.
Find a Location
Who is running the clinical trial?
Jinka SathyaLead Sponsor
Lawson Health Research InstituteLead Sponsor
665 Previous Clinical Trials
414,155 Total Patients Enrolled
Jinka Sathya, MDPrincipal InvestigatorWestern University
1 Previous Clinical Trials
112 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had a skin reaction to light in the past, or have a medical condition that makes your skin sensitive to hydrogen peroxide.The area being studied has unclear or blurry boundaries.You have a condition called Gorlins syndrome which makes you more likely to develop multiple skin cancers. It is important for you to have regular check-ups and catch any cancer early.If you have a weakened immune system, you will not be able to participate because skin cancers can be very aggressive.
Research Study Groups:
This trial has the following groups:- Group 1: 30% hydrogen peroxide
- Group 2: 3% hydrogen peroxide
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger